KIORA PHARMACEUTICALS, INC. Accounts Payable
KIORA PHARMACEUTICALS, INC. (KPRX) had Accounts Payable of $216.50 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Payable, Current $216.50K.
- 2026-03-31: Accounts Payable, Current $594.87K.
- 2025-12-31: Accounts Payable, Current $1.06M.
- 2025-09-30: Accounts Payable, Current $241.47K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $216.50K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $594.87K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.06M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $241.47K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $282.54K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $942.49K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $415.59K 10-K · filed 2026-03-25 |
| 2024-09-30 | $660.41K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $268.64K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $323.06K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $206.26K 10-K · filed 2025-03-25 |
| 2023-09-30 | $125.41K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $131.32K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $587.47K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.01M 10-K · filed 2024-03-25 |
| 2022-09-30 | $749.19K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $785.77K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $302.26K 10-Q · filed 2022-07-08 |
| 2021-12-31 | $160.62K 10-K · filed 2023-03-23 |
| 2021-09-30 | $424.89K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $292.32K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $457.35K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $434.76K 10-K/A · filed 2022-07-07 |
| 2020-09-30 | $59.53K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $94.30K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $158.03K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $210.29K 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.07M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $96.58K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $244.19K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $63.65K 10-K · filed 2020-03-04 |
| 2018-09-30 | $324.18K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $356.02K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $221.88K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $706.09K 10-K · filed 2019-03-01 |
| 2017-09-30 | $658.62K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $970.91K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $1.31M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $1.41M 10-K · filed 2018-03-02 |
| 2016-09-30 | $1.40M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $1.23M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $869.34K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $417.70K 10-K · filed 2017-02-23 |
| 2015-09-30 | $158.13K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $337.61K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $286.23K 10-Q · filed 2015-05-18 |
| 2014-12-31 | $565.95K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |